Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy
Crossref DOI link: https://doi.org/10.1007/s11239-018-1617-2
Published Online: 2018-01-25
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sartori, Michelangelo http://orcid.org/0000-0003-3466-4676
Cosmi, Benilde
Text and Data Mining valid from 2018-01-25
Article History
First Online: 25 January 2018
Compliance with Ethical Standards
:
: The authors declare that they have no conflict of interests.